Skip to main content
Pipeline
Overview
Stenoparib
Ixempra
®
Dovitinib
Additional Programs
Clinical Trials
Technology
The DRP
®
Method
Scientific Publications
About Us
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering
Investors
Contact
General Inquires
Careers
Join Allarity
Menu
Pipeline
Overview
Stenoparib
Ixempra
®
Dovitinib
Additional Programs
Clinical Trials
Technology
The DRP
®
Method
Scientific Publications
About Us
Overview
Leadership
Board of Directors
Scientific Advisory Board
Partnering
Investors
Overview
News
Stock Info
Financials
Governance
Resources
Contact
General Inquires
Careers
Join Allarity
Overview
News
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Investor Email Alerts
Investor Contacts
Presentations
Site Search
Search query
Analyst Coverage
Overview
News
Stock Info
Stock Quote
Stock Chart
Historical Stock Quote
Investment Calculator
Analyst Coverage
Financials
Annual Reports
SEC Filings
Governance
Governance Documents
Executive Management
Board of Directors
Committee Composition
Resources
Investor Email Alerts
Investor Contacts
Presentations
Firm
Analyst
Coverage
Ladenburg Thalmann & Co. Inc.
Aydin Huseynov, M.D., CFA
Reverse Stock Split and Mono Stenoparib Data in 2H23
Zacks Investment Research, Inc.
John D. Vandermosten, CFA
A Precision Undertaking